# Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression

> **NCT05177146** · NA · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 16 (actual)

## Conditions studied

- Bipolar Disorder (BD)
- Suicidality

## Interventions

- **DRUG:** Intravenous Ketamine (IV)

## Key facts

- **NCT ID:** NCT05177146
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-04
- **Primary completion:** 2025-01-10
- **Final completion:** 2025-01-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177146, "Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05177146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*